Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies that could help oncology and immunology patients. Their pipeline has 3 interesting Phase 1 candidates for SLE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback